Connect Sleuth to the AI tool your team already uses, and it works from a knowledge base built for biopharma instead of a fresh web search. In our tests, Claude, ChatGPT, and Perplexity found 63% more of the landscape, every time.
63%
more of the landscape found with Sleuth connected, on average across 15 tests
We asked Claude, ChatGPT, and Perplexity five biopharma questions, on their own and with Sleuth connected. Every answer with Sleuth connected listed more: 63% more on average, and 40% at the median.
15 of 15
tests found more with Sleuth connected, in September 2026
+55%
Claude
+27%
ChatGPT
+108%
Perplexity
Asked for I&I deals with $50M or more upfront, Claude on its own marked royalty terms “not disclosed” on 52% of its rows. With Sleuth connected, 89% of rows had real terms.
52%
of rows read “not disclosed” from Claude on its own
89%
of rows had real terms with Sleuth connected
Each test goes on the study page, including the ones where the gain was small.
How we ran it, and what the test doesn’t show, sit next to the results.
The study page has the exact questions, so you can ask them in your own AI tool.
Each study names its date and the versions tested. A rerun is added beside it, never swapped in.